NLRP3 Inflammasome Contributes to Lipopolysaccharide-induced Depressive-Like Behaviors via Indoleamine 2,3-dioxygenase Induction
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background: Inflammation may play a significant role in the pathogenesis of depression, although the molecular target for the treatment of inflammation-mediated depressive symptoms remains to be elucidated. Recent studies have implicated the NLRP3 inflammasome in various psychiatric disorders, including depression. However, the underlying mechanism by which NLRP3 inflammasome activation mediates the progression of depressive-like behaviors remains poorly understood. Methods: We examined whether NLRP3 deficiency influenced depressive-like behaviors and cerebral inflammation following systemic administration of lipopolysaccharide in mice. To further assess the contribution of the NLRP3 inflammasome to the progression of depression, we evaluated the effects of NLRP3 signaling on levels of indoleamine 2,3-dioxygenase. Results: Nlrp3-deficient mice exhibited significant attenuation of depressive-like behaviors and cerebral caspase-1 activation in a lipopolysaccharide-induced model of depression. Treatment with the antidepressant amitriptyline failed to block NLRP3-dependent activation of caspase-1, but inhibited lipopolysaccharide-promoted production of interleukin-1β mRNA via suppressing NF-κB signaling in mouse mixed glial cultures. Interestingly, lipopolysaccharide administration produced NLRP3-dependent increases in indoleamine 2,3-dioxygenase expression and activity of mouse brain. Furthermore, inflammasome-activating stimulations, but not treatment with the inflammasome product interleukin-1β, triggered indoleamine 2,3-dioxygenase mRNA induction in mixed glial cells. Conclusions: Our data indicate that the NLRP3 inflammasome is significantly implicated in the progression of systemic inflammation-induced depression. NLRP3-dependent caspase-1 activation produced significant increases in indoleamine 2,3-dioxygenase levels, which may play a significant role in lipopolysaccharide-induced depression. Collectively, our findings suggest that indoleamine 2,3-dioxygenase is a potential downstream mediator of the NLRP3 inflammasome in inflammation-mediated depressive-like behaviors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it has been observed that stimulating NLRP3 inflammasome assembly can induce depression-like behaviors in rodents exposed to LPS or CUMS. 156 , 157”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Research on the effect of astrocyte-specific NLRP3 knockout suggests that the astrocytic NLRP3 inflammasome exerts a significant effect on astrocytic pyroptosis via the Casp-1/GSDMD pathway in depression. 156 , 157”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [156]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 3×
“On a mechanistic basis, cytokines produced via peripheral inflammation can cross the blood-brain barrier through diffusion or some transporters and activate afferent nerves, possibly contributing to the etiology of psychiatric disorders (Dantzer et al., 2008).”
BackgroundMethodSchroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475 · cited 1×
“An inflammasome is a cytoplasmic caspase-1-activating multiprotein complex that is composed of a sensor protein such as NLRP3, an adaptor protein apoptosis-associated speck-like protein containing a caspase-recruitment domain, and an effector protein procaspase-1 (Schroder and Tschopp, 2010).”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“In detail, the production level of proinflammatory cytokines is frequently elevated in patients with major depression (Dowlati et al., 2010).”
BackgroundDepression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · cited 1×
“At 28 h post-injection, the forced swim test (FST) was then conducted as previously described (Porsolt et al., 1977; O’Connor et al., 2009).”
MethodThe role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 3×
“Emerging evidence has suggested that IDO acts as a central mediator of cytokine-induced depression (O’Connor et al., 2009; Walker et al., 2014; Miller and Raison, 2016) and that systemic LPS administration induces a manifest upregulation of IDO in the hippocampal region (Andre et al., 2008; Walker…”
BackgroundInfluentialThe tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534 · cited 1×
“At 24 hours post injection, body weights of mice were measured, and the tail suspension test (TST) was then performed as previously described (Steru et al., 1985; O’Connor et al., 2009).”
MethodNLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 2×
“In addition, recent studies have also proposed that NLRP3 inflammasome activation may be implicated in neuroinflammation, neurodegenerative disorders (Heneka et al., 2013; Jang et al., 2016; Zhang et al., 2016), and neuropsychiatric disorders such as depression (Alcocer-Gomez et al., 2014).”
BackgroundBelmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · cited 1×
“However, deregulated inflammasome activation has been increasingly implicated in the pathogenesis of metabolic or neurodegenerative disorders (Henao-Mejia et al., 2014; Heneka et al., 2014).”
Background
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“156,157 Research on the effect of astrocyte-speci fi c NLRP3 knockout suggests that the astrocytic NLRP3 in fl ammasome exerts a signi fi cant effect on astrocytic pyroptosis via the Casp-1/GSDMD pathway in depression.”
BackgroundArioz, B. I., Tastan, B., Tarakcioglu, E., Tufekci, K. U., Olcum, M., Ersoy, N., Bagriyanik, A., Genc, K., & Genc, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01511 · Cited by 516
“Behavioral and molecular evidences of DLB being inhibited by NLRP3 inhibitor support that inflammasome activation plays role in the disease pathogenesis (19).”
BackgroundLi, S., Sun, Y., Song, M., Song, Y., Fang, Y., Zhang, Q., Li, X., Song, N., Ding, J., Lu, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146852 · Cited by 321
“tion or chronic unpredictable mild stress (CUMS) stimulation (50, 51).”
BackgroundDepression's Unholy Trinity: Dysregulated Stress, Immunity, and the Microbiome
Cruz-Pereira, J. S., Rea, K., Nolan, Y. M., O'Leary, O. F., Dinan, T. G., & Cryan, J. F. (2020) · Annual Review of Psychology · doi:10.1146/annurev-psych-122216-011613 · Cited by 320
“In a fascinating study, cerebral cavernous malformations—vascular defects that potentiate the risk of seizure and hemorrhagic stroke—were found to be stimulated by activation of endothelial Toll-like receptor 4 (TLR4), which is involved in the activation of innate immunity, by gram-negative bacteria and LPS (Tang et a…”
BackgroundInfluentialKouba, B. R., de Araujo Borba, L., Borges de Souza, P., Gil-Mohapel, J., & Rodrigues, A. L. S. (2024) · Cells · doi:10.3390/cells13050423 · Cited by 209
“However, in a different study, amitriptyline (20 or 50 µ M for 1 h) was unable to mitigate caspase-1 activation after stimulation of mouse glial cells with LPS/ATP or LPS/nigericin [234].”
BackgroundFeng, X., Zhao, Y., Yang, T., Song, M., Wang, C., Yao, Y., & Fan, H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00210 · Cited by 183
“, 2016) and neuropsychiatric disorders such as depression (Jeon et al., 2017).”
BackgroundThe NLRP3 inflammasome in depression: Potential mechanisms and therapies
Xia, C.-Y., Guo, Y.-X., Lian, W.-W., Yan, Y., Ma, B.-Z., Cheng, Y.-C., Xu, J.-K., He, J., & Zhang, W.-K. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106625 · Cited by 178
Zhang, L., Previn, R., Lu, L., Liao, R.-F., Jin, Y., & Wang, R.-K. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.08.021 · Cited by 173
Li, W., Ali, T., Zheng, C., Liu, Z., He, K., Shah, F. A., Ren, Q., Rahman, S. U., Li, N., Yu, Z.-J., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02091-5 · Cited by 145
“LPS is a well-established inflammatory agent and widely employed to induce depressive-like behavior [51, 57].”
BackgroundLasselin, J., Lekander, M., Benson, S., Schedlowski, M., & Engler, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00869-2 · Cited by 114
Zhao, Z., Wang, Y., Zhou, R., Li, Y., Gao, Y., Tu, D., Wilson, B., Song, S., Feng, J., Hong, J.-S., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1728-5 · Cited by 109
Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
Shao, B.-Z., Cao, Q., & Liu, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00320 · Cited by 102
“NLRP3-dependent caspase-1 activation was reported to be significantly implicated in the progression of systemic inflammation-induced depression triggered by LPS in mice depression model (Jeon et al., 2017).”
BackgroundLiu, T., Ma, Y., Zhang, R., Zhong, H., Wang, L., Zhao, J., Yang, L., & Fan, X. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5148-5 · Cited by 98
Li, D., Wang, C.-N., Wang, Y., Ye, C., Jiang, L., Zhu, X., & Liu, Y. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112684 · Cited by 80
Predictable chronic mild stress promotes recovery from LPS-induced depression
Dang, R., Guo, Y., Zhang, K., Jiang, P., & Zhao, M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0463-2 · Cited by 65
NLRP3 Inflammasome: From Pathophysiology to Therapeutic Target in Major Depressive Disorder
Kouba, B. R., Gil‐Mohapel, J., & Rodrigues, A. L. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010133 · Cited by 62
“) has been shown to increase the expression and activity of IDO in the hippocampus while also inducing depressive-like behaviors in C57BL/6 mice in an NLRP3-dependent manner [51].”
BackgroundGong, W., Zhang, S., Zong, Y., Halim, M., Ren, Z., Wang, Y., Ma, Y., Li, B., Ma, L., Zhou, G., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.05.009 · Cited by 52
Self-citationChaves-Filho, A. J. M., Macêdo, D. S., de Lucena, D. F., & Maes, M. H. J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111975 · Cited by 51
Amplifying Ca2+ overload by engineered biomaterials for synergistic cancer therapy
Liang, J., Cao, Y., Lv, K., Xiao, B., & Sun, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.123027 · Cited by 41
Liu, P., Bai, X., Zhang, T., Zhou, L., Li, J., & Zhang, L. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.64 · Cited by 38
NLRP3 deficiency-induced hippocampal dysfunction and anxiety-like behavior in mice
Komleva, Y. K., Lopatina, O. L., Валерьевна, Г. Я., Shuvaev, А. N., Chernykh, A., Potapenko, I., & Salmina, A. B. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147220 · Cited by 38
Bian, H., Wang, G., Huang, J.-J., Liang, L., Xiao, L., & Wang, H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106943 · Cited by 37
Agmatine as a novel candidate for rapid-onset antidepressant response
Valverde, A. P., Camargo, A., & Rodrigues, A. L. S. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i11.981 · Cited by 33
Adenovirus VA RNAI Blocks ASC Oligomerization and Inhibits NLRP3 Inflammasome Activation
Darweesh, M. F., Kamel, W., Gavrilin, M. A., Akusjärvi, G., & Svensson, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02791 · Cited by 30
“Aberrant activation of the inflammasomes has been implicated in different neurological, autoimmune, cardiovascular, and malignant diseases (68).”
BackgroundZhang, S., Zong, Y., Ren, Z., Hu, J., Wu, X., Xiao, H., Qin, S., Zhou, G., Ma, Y., Zhang, Y., et al. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15016 · Cited by 29
“NLRP3 blockade not only improved LPS-induced depressive-like behavior but also reduced IDO expression and activity (Jeon et al., 2017).”
BackgroundSelf-citationDu, R.-W., & Bu, W.-G. (2020) · Experimental Brain Research · doi:10.1007/s00221-020-05911-x · Cited by 28
Camargo, A., Dalmagro, A. P., Wolin, I. A. V., Kaster, M. P., & Rodrigues, A. L. S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.057 · Cited by 26
Dal‐Pizzol, F., de Medeiros, G. F., Michels, M., Mazeraud, A., Bozza, F. A., Ritter, C., & Sharshar, T. (2021) · Neurotherapeutics · doi:10.1007/s13311-020-00981-9 · Cited by 26
Huang, D., Li, G., Bhat, O. M., Zou, Y., Li, N., Ritter, J. K., & Li, P. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.10.005 · Cited by 19
“As an ASM inhibitor, amitriptyline reportedly inhibits both NLRP3 inflammasome activation and exosome release.(19,24,25) In the present study, the exosome biogenesis inhibitor GW4869, the lysosome function enhancer rapamycin, and the ASM inhibitor amitriptyline were used to test whether hHcy-induced exosome release fr…”
BackgroundPotential role of gut microbiota in major depressive disorder: A review
Khaledi, M., Sameni, F., Gholipour, A., Shahrjerdi, S., Golmohammadi, R., Ghaleh, H. E. G., Poureslamfar, B., Hemmati, J., Mobarezpour, N., Milasi, Y. E., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33157 · Cited by 20
“Cytokines produced through environmental inflammation can cross the blood-brain barrier, activate the afferent nerves, and contribute to depressive disorders [168,171].”
BackgroundMaciak, K., Dziedzic, A., & Saluk, J. (2022) · The FASEB Journal · doi:10.1096/fj.202201348r · Cited by 22
TDAG51 is a crucial regulator of maternal care and depressive-like behavior after parturition
Yun, H., Park, E., Choi, S., Shin, B., Yu, J., Yu, J., Amarasekara, D. S., Kim, S., Lee, N., Choi, J., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008214 · Cited by 18
Self-citationGuo, J., Fang, M., Xiong, Z., Zhou, K., & Zeng, P. H. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02628-w · Cited by 17
“In this study, we used an LPS-induced depression mouse model (Sekio and Seki 2014; Jeon et al. 2017; Li et al. 2021b) to assess the antidepressant effects of CUR.”
Lu, J., Zhang, Y., Qian, H. R., Zhou, H., & Zong, Y. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2262741 · Cited by 14
Ali, M. A., Michel, H. E., Menze, E. T., Tadros, M., & Wahdan, S. A. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177525 · Cited by 12
Shentu, Y., Chen, M., Wang, H., Du, X., Zhang, W., Xie, G., Zhou, S., Ding, L., Zhu, Y., Zhu, M., et al. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114586 · Cited by 12
Self-citationWang, B., Tian, L., Wu, M., Zhang, D., Yan, X., Bai, M., Li, Y., Su, P., & Xu, E. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112451 · Cited by 13
“…which can effectively activate NLRP3 inflammasome, and therefore, NLRP3 inflammasomes are considered to be a bridge between stress and depression, playing critical roles in converting psychological stress into an inflammatory response (Jeon et al., 2017; Kaufmann et al., 2017; Maciak et al., 2023).”
BackgroundInosine exerts dopaminergic neuroprotective effects via mitigation of NLRP3 inflammasome activation
Khanal, S., Shin, E., Yoo, C. J., Kim, J., & Choi, D. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110278 · Cited by 12
Kynurenine pathway of tryptophan metabolism in patients with familial Mediterranean fever
Tezcan, D., Onmaz, D. E., Sivrikaya, A., Körez, M. K., Hakbilen, S., Gülcemal, S., & Yilmaz, S. (2022) · Modern Rheumatology · doi:10.1093/mr/roac016 · Cited by 11
Liu, F., Wang, Y., Li, D., & Yang, T. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578349 · Cited by 11
Mo, X., Guo, S., He, D., Cheng, Q., Yang, Y., Wang, H., Ren, Y., Liu, L., & Xie, P. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00739-8 · Cited by 10
McColgan, L., McNaugher, G. A., Church, M., Murray, E. K., Kelly, C., Coyle, S., & McGilligan, V. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117003 · Cited by 11
Liu, S., Zhang, Y., Zhou, H., Ma, Y., Huang, F., Lei, T., Wang, Q., & Yu, S. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c09773 · Cited by 9
Ding, L., Xue, L., Cheng, C., Tang, K., Chen, Z., & Du, G. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111592 · Cited by 14
Mafikandi, V., Seyedaghamiri, F., Hosseinzadeh, N., Shahabi, P., Shafiee‐Kandjani, A. R., Babaie, S., Maghsoumi‐Norouzabad, L., Farajdokht, F., & Hosseini, L. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03487-9 · Cited by 10
“The activation of the NLRP3/Cas1 axis meaningfully increased systemic inflammation caused by lipopolysaccharide-induced depression in mice (Jeon et al. 2017).”
Therapeutic effects of exercise on depression: The role of microglia
Li, L., Ren, L., Li, B., & Liu, C. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149279 · Cited by 7
Boo, K.-J., Gonzales, E. L., Remonde, C. G., Seong, J. Y., Jeon, S. J., Park, Y., Ham, B., & Shin, C. Y. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.073 · Cited by 8
“Since indoleamine 2,3-dioxygenase 1 (IDO1) is one of the critical mediators in inflammation-mediated depressivelike behaviors (Jeon et al., 2017) that is activated by toll-like receptor 4 (TLR4)-related ligands and the IFN family (HoyoBecerra et al., 2014; Suento et al., 2021); we conducted the…”
BackgroundInfluentialSelf-citationHuang, M., Chen, F., Zhou, L., Zhang, Q., Wang, L., Li, L., Yang, L., Gao, M., Li, L., Wang, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1569888 · Cited by 10
Self-citationLv, S., Kong, L., Zhong, X., Shang, R., Lu, Y., Zhang, G., Gao, H., Hou, X., Li, G., & Yu, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1642001 · Cited by 6
Chen, Z., Liu, H., Ye, Y., Chen, D., Lu, Q., Lu, X., & Huang, C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108924 · Cited by 7
Elzaitony, A. S., Al‐Najjar, A. H., Gomaa, A. A., Eraque, A. M. S., & Sallam, A. S. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.117043 · Cited by 5
Chen, C., Yu, R., Xue, Z., Yan, Z., Bian, Q., Hou, Y., Chen, Y., Liu, Y., & Chen, J. (2020) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2020.08.001 · Cited by 5
Wang, M., Xia, C., Guo, Y., Zuo, G., Cheng, Y., Yang, H., Zhang, W., He, J., & Xu, J. (2025) · Phytotherapy Research · doi:10.1002/ptr.70141 · Cited by 4
“NLRP3-deficient mice exhibit stress resilience in rodent models (Jeon et al. 2017), and numerous antidepressant drugs reverse depressive behaviors while inhibiting the NLRP3/ Caspase-1/IL-1β signaling pathway (Alcocer-Gómez et al. 2017; Lachance et al. 2023).”
Neamtu, M., Petreus, T., Temelie-Olinici, D., Stoica, L., Arcan, O. D., Stoica, B. A., & Moşoiu, C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073127 · Cited by 4
Hu, J., Li, X., Tang, M., Wan, M., Zhang, S., Wu, H., Li, M., Wang, L., Xiao, H., Zhu, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-96268-0 · Cited by 4
“The open field test (OFT), tail suspension test (TST), and forced swim test (FST) were conducted in sequence with 2-hour intervals using standard protocols to confirm their depressive states 20,21 .”
Exploring the potential of drug repurposing for treating depression
Verma, C., Jain, K., Saini, A., Mani, I., & Singh, V. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.037 · Cited by 3
Global trends of purinergic receptors and depression: A bibliometric analysis from 2003 to 2023
Chen, W., Peng, C., Shen, X., Li, H., Chen, W., Chen, W., Yan, C., & Huang, B. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i2.102344 · Cited by 1
Purinergic Signaling in Depression
Ribeiro, D. E., Kaster, M. P., Ulrich, H., Lisboa, S. F. D. S., & Joca, S. R. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-26945-5_7
Die Aktivität des NLRP3-Inflammasoms bei depressiven Patienten in Abhängigkeit von Kindheitstraumata
Lechner, K. (2025) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-40044
Gu, J.-Y., Di, D.-C., Gu, M.-Y., & Liu, H. (2026) · Annals of General Psychiatry · doi:10.1186/s12991-026-00632-x
Dworsky‐Fried, M., Iqbal, U. H., Bronner, S., Auger, J., Mathieu, O., Auclair‐Ouellet, N., Liang, J., & Ismail, N. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101341
“NLRP3 also upregulates indoleamine 2,3-dioxygenase (IDO), linking neuroinflammation to the kynurenine pathway and depression-like behaviour (Jeon et al., 2017).”
Metadata
- Authors
- Jeon, S.-A., Lee, E., Hwang, I., Han, B., Park, S., Son, S., Yang, J., Hong, S., Kim, C. H., Son, J., & Yu, J.-W.
- Affiliations
- Yonsei University (KR)
- Corresponding author
- Yu, Je-Wook
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-07-31
- Volume
- 20
- Issue
- 11
- Pages
- 896-906
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC5737528
- OpenAlex
- W2741260697
- Cited by
- 62
- References
- 44
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 12 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 11 · 2018: 2
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Research Foundation of Korea (2014R1A4A1008625, 2017R1A2B2007467)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- NLRP3 inflammasome, depression, lipopolysaccharide, indoleamine 2,3-dioxygenase, caspase-1, IL-1β, NF-κB signaling, systemic inflammation, depression-like behavior, amitriptyline, neuroinflammation
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Amitriptyline, Analysis of Variance, Animals, Brain, Cells, Cultured, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Lipopolysaccharides, Mice, Inbred C57BL, Neuroglia, RNA, Messenger, Gene Expression Regulation, Enzymologic, Cytokines, Mice, Knockout, Caspase 1, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.